Learn more

INST ORCH SINTEZA AN LATSSR

Overview
  • Total Patents
    15
About

INST ORCH SINTEZA AN LATSSR has a total of 15 patent applications. Its first patent ever was published in 1973. It filed its patents most often in USSR (Union of Socialist Soviet Republics). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ELOXX PHARMACEUTICALS LTD, GENSIA SICOR and GLYCIM OY.

Patent filings in countries

World map showing INST ORCH SINTEZA AN LATSSRs patent filings in countries
# Country Total Patents
#1 USSR (Union of Socialist Soviet Republics) 15

Patent filings per year

Chart showing INST ORCH SINTEZA AN LATSSRs patent filings per year from 1900 to 2020

Focus industries

Focus technologies

Top inventors

# Name Total Patents
#1 Slavinskaya Valentina A 4
#2 Lavrinovich E S 4
#3 Krejle Dzidra R 2
#4 Baumane G K 2
#5 Gejman Ina I 2
#6 Trapentsier P T 2
#7 Germane S K 2
#8 Kalvinsh I Ya 2
#9 Liepinsh E E 2
#10 Dzilyuma Emiliya E 2

Latest patents

Publication Filing date Title
SU1204620A1 Method of producing 2-methyl-4,5-dihydrofuran
SU1131870A1 Process for preparing bromovalerianic acid
SU978908A1 Catalyst for dehydration of butanediol-1,4 or butene-2-diol-1,4
SU784218A1 Synthetic analog of natural taphcinpeptide possessing phagocytostimulating activity
SU792872A1 Method of preparing 2-(isoxazolyl-5)-benzoic acid
SU857132A1 Method of preparing piperidine
SU681808A1 2,2-disubstituted 1,3,4-triazabicyclo(4,10)-heptan-5-ones and process for preparing same
SU689152A1 1-alkoxycarbonyl-2-carbamoylaziridines as semiproducts for synthesis of carcinostatics and immunostimulators
SU616721A1 Fungicide
SU630766A1 Fungicide
SU542393A1 Method of preparing dimethylaminosulfochloride
SU551871A1 2-arylpiperazino-2-phenylindanones possessing psychotropic properties
SU567287A1 Derivatives of ethyl ester of 2-methyl-4-oxyquinoline-3-carboxalic acid as inttnrmediate products for synthesis of compounds possessing antiblastic and antibacterial action and their preparation method
SU530520A1 Method of preparing ribonucleoside-5'-monophosphates labeled with c or h isotopes
SU1179997A1 Agent for curing parkinsonism "gludantan"